Bloomberg

J&J shot's U.S. future depends on 15 cautious vaccine experts

Foto: PR/Johnson & Johnson

Advisers to the Centers for Disease Control and Prevention are under pressure to decide whether the U.S. can resume use of Johnson & Johnson's covid-19 vaccine, perhaps with some limits, 10 days into a pause on using it.

Members of CDC's Advisory Committee on Immunization Practices will reconvene Friday to decide whether they have enough data to say who should -- or shouldn't -- receive J&J's shot. Options include a full resumption, restrictions by age or gender, or possibly extending the pause...

BRANCHENYT
Læs også